Phosphorylated TBK1 promotes activation of the NF-κB signaling pathway, promoting a stem-like phenotype in melanoma and serving as a driver of chemoresistance in melanoma therapy (X. Zhu et al., 2019). This evidence concerns the gene NFKB1 and melanoma.